CTMX · CytomX Therapeutics, Inc. · Executive Compensation

$2.51 +0.17 (+7.26%) At close · Oct 20

Russell 2000 member Rebalance outlook locked

Market Cap

$546.93M

217.90M

Volume · Oct 20 4.1M Avg daily vol (3M) 3.29M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Sean McCarthy	D. Phil. Chief Executive Officer and Chairman of the Board of Directors	$652,088	—	$1,048,950	$533,201	$371,899	$5,000	$2,611,138
Marcia P. Belvin	Senior Vice President, and Chief Scientific Officer	$459,827	—	$402,250	$169,270	$170,000	$5,000	$1,206,347
Jeff Landau	Senior Vice President and Chief Business Officer	$415,692	—	$297,850	$169,270	$160,000	$5,000	$1,047,812

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Sean McCarthy	D. Phil. Chief Executive Officer and Chairman of the Board of Directors	$622,893	—	$429,000	$1,559,160	$397,553	$5,000	$3,013,606
Carlos Campoy	Former Senior Vice President and Chief Financial Officer	$349,479	—	$92,925	$330,723	—	$647,144	$1,420,271
Lloyd A. Rowland	Senior Vice President,	$425,193	—	$128,700	$467,748	$178,525	$5,000	$1,205,166
Jeff Landau	Senior Vice President and Chief Business Officer	$393,333	—	$102,987	$376,233	$183,350	$5,000	$1,060,903

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Sean McCarthy	D. Phil. Chief Executive Officer and Chairman of the Board of Directors	$615,825	—	$427,200	$2,931,890	$359,500	$5,000	$4,339,415
Amy Peterson	Former President and Chief Operating Officer	$520,605	—	$213,600	$1,246,265	$266,810	$5,000	$2,252,280
Jeff Landau	Senior Vice President and Chief Business Officer	$274,924	$115,000	$120,150	$1,127,559	$112,688	$5,000	$1,755,321
Alison L. Hannah	Senior Vice President and Chief Medical Officer	$464,400	—	$160,200	$887,172	$190,404	$5,000	$1,707,176
Lloyd A. Rowland	Senior Vice President,	$417,778	—	$160,200	$667,492	$171,288	$5,000	$1,421,758
Carlos Campoy	Former Senior Vice President and Chief Financial Officer	$477,555	—	$160,200	$557,652	$195,797	$5,000	$1,396,204

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Sean McCarthy	D. Phil. Chief Executive Officer and Chairman of the Board of Directors	$595,000	—	—	$1,892,850	$357,000	$5,000	$2,849,850
Carlos Campoy	Senior Vice President, Chief Financial Officer	$360,052	—	—	$972,860	$144,723	$264,004	$1,741,639
Alison L. Hannah	Senior Vice President and Chief Medical Officer	$412,500	—	—	$1,023,425	$197,063	$45,000	$1,677,988
Lloyd A. Rowland	Senior Vice President, General Counsel, Chief Compliance Officer and Secretary	$403,650	—	—	$378,570	$161,460	$9,713	$953,393
Amy Peterson	President, Chief Operating Officer	$503,000	—	—	$94,643	$301,800	—	$899,442

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Sean McCarthy	D. Phil. Chief Executive Officer and Chairman of the Board of Directors	$575,000	—	—	$2,862,180	$327,750	$5,000	$3,769,930
Amy Peterson	President, Chief Operating Officer	$107,955	—	—	$1,548,000	$41,907	$1,697,861	$3,395,723
Rachel Humphrey	Former Senior Vice President and Chief Medical Officer	$289,761	—	—	$858,654	—	$833,897	$1,871,354
W. Michael Kavanaugh	Former Senior Vice President, Chief Science Officer and Head of Research and Non-Clinical Development	$444,452	—	—	$858,654	$168,892	$5,000	$1,476,997
Lloyd A. Rowland	Senior Vice President, General Counsel, Chief Compliance Officer and Secretary	$390,000	—	—	$523,779	$132,600	$51,464	$1,097,843
Debanjan Ray	Former Senior Vice President and Chief Financial Officer	$153,563	—	—	$858,654	—	$52,461	$1,063,677
Carlos Campoy	Senior Vice President, Chief Financial Officer	—	—	—	—	—	—	—
Alison L. Hannah	Senior Vice President and Chief Medical Officer	—	—	—	—	—	—	—

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Sean McCarthy	D. Phil. President, Chief Executive Officer and Chairman of the Board of Directors	$550,000	—	—	$4,514,280	$412,500	$5,453	$5,482,233
Rachel Humphrey	Former Senior Vice President and Chief Medical Officer	$440,448	—	—	$1,504,760	$220,224	$125,387	$2,290,819
Debanjan Ray	Former Senior Vice President and Chief Financial Officer	$393,750	—	—	$1,504,760	$196,875	$5,000	$2,100,385
W. Michael Kavanaugh	Former Senior Vice President, Chief Science Officer and Head of Research and Non-Clinical Development	$427,357	—	—	$1,128,570	$213,679	$5,000	$1,774,606
Lloyd A. Rowland	Senior Vice President, General Counsel, Chief Compliance Officer and Secretary	$360,000	—	—	$1,447,650	$110,466	$26,586	$26,586
Amy Peterson	Executive Vice President, Chief Development Officer	—	—	—	—	—	—	—
Alison L. Hannah	Senior Vice President and Chief Medical Officer	—	—	—	—	—	—	—
Carlos Campoy	Senior Vice President, Chief Financial Officer	—	—	—	—	—	—	—

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Sean McCarthy	D. Phil. President, Chief Executive Officer and Chairman of the Board of Directors	$500,000	—	—	$2,284,886	$425,000	$3,453	$3,213,339
Rachel Humphrey	Former Senior Vice President and Chief Medical Officer	$410,800	—	—	$884,472	$244,426	$69,647	$1,609,345
Debanjan Ray	Former Senior Vice President and Chief Financial Officer	$351,126	—	—	$980,246	$228,750	$3,000	$1,563,122
W. Michael Kavanaugh	Senior Vice President, Chief Science Officer and Head of Research and Non-Clinical Development	$410,921	—	—	$884,472	$201,351	$3,000	$1,499,744

Executive changes

Person	Role	Change	Effective	Filed
Charles Fuchs, M.D., M.P.H.	Class II director	Appointed	2026-07-24	2026-07-27
Elaine V. Jones Ph.D.	Class II director	Appointed	2026-06-17	2026-06-22
Matthew P. Young	Class II director	Appointed	2026-06-17	2026-06-22
Jeffrey Landau	Senior Vice President, Chief Business Officer, and Head of Strategy	Terminated	2025-02-07	2025-02-03
Chris Ogden	Chief Financial Officer	Appointed	2024-06-15	2024-06-17
Zhen Su, M.D., M.B.A.	Class I director	Appointed	2024-03-20	2024-03-22
Carlos Campoy	SVP, Chief Financial Officer	Terminated	2022-09-30	2022-09-23
Chris Ogden	principal financial officer and principal accounting officer	Appointed	2022-09-21	2022-09-23
Alison Hannah, M.D.	SVP, Chief Medical Officer	Terminated	2022-09-30	2022-07-13
Carlos Campoy	SVP, Chief Financial Officer	Terminated	2022-09-30	2022-07-13
Amy Peterson, M.D.	President and Chief Operating Officer	Terminated	2022-09-12	2022-07-13

Leadership

Sean McCarthy CEO, Board Member
Chris Ogden CFO, Chief Accounting Officer
Lloyd A. Rowland General Counsel
Alan Ashworth Board Member
Alan Ashworth, Ph.D., FRS Board Member
Charles Fuchs, M.D., M.P.H. Board Member
Elaine V. Jones Board Member
Elaine V. Jones Ph.D Board Member
Elaine V. Jones Ph.D. Board Member
Halley Gilbert Board Member
James R. Meyers Board Member
Mani Mohindru Board Member
Mani Mohindru, Ph.D. Board Member
Matthew P. Young Board Member
Sean A. McCarthy, D. Phil. Board Member
Zhen Su Board Member
Zhen Su, M.D., M.B.A. Board Member

Key facts CIK 1501989 CUSIP 23284F105 13F (30d) 11 filings 11 filers Visit website Investor relations